Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymoma

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 5, 2011, Pages

  Fabre, Dominique ^a   Fadel, Elie ^a   Mussot, Sacha ^a   Mercier, Olaf ^a   Petkova, Boriana ^a   Besse, Benjamin ^a   Huang, James ^a   Dartevelle, Philippe G ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

Extrapleuralpneumonectomy; Masaoka stage IVa; Survival; Thymoma

Indexed keywords

ADULT; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH CENTER; HUMAN; LUNG RESECTION; MALE; MORTALITY; MYASTHENIA GRAVIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL TIME; THYMOMA; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; ALGORITHMS; BRONCHIAL FISTULA; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PLEURAL DISEASES; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; RECURRENCE; RESPIRATORY TRACT FISTULA; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 79954568198     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.12.064     Document Type: Article

References (25)

1. Ishikawa Y., Matsuguma H., Nakahara R., Suzuki H., Ui A., Kondo T., Kamiyama Y., Igarashi S., Mori K., Kodama T., Yokoi K. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy. Ann Thorac Surg 2009, 88:952-957.
2. Wright C.D. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg 2006, 82:1234-1239.
3. Lucchi M., Davini F., Ricciardi R., Duranti L., Boldrini L., Palmiero G., Basolo F., Mussi A. Management of pleural recurrence after curative resection of thymoma. J Thorac Cardiovasc Surg 2009, 137:1185-1189.
4. Huang J., Rizk N.P., Travis W.D., Seshan V.E., Bains M.S., Dycoco J., Downey R.J., Flores R.M., Park B.J., Rusch V.W. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 2007, 134:1477-1483. [discussion 1483-1474].
5. Masaoka A., Monden Y., Nakahara K., Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981, 48:2485-2492.
6. Histological typing of tumors of the thymus 1999, J.S.L. Rosai (Ed.).
7. Rena O., Papalia E., Maggi G., Oliaro A., Ruffini E., Filosso P., Mancuso M., Novero D., Casadio C. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 2005, 50:59-66.
8. Strobel P., Marx A., Zettl A., Muller-Hermelink H.K. Thymoma and thymic carcinoma: an update of the WHO classification 2004. Surg Today 2005, 35:805-811.
9. Sugarbaker D.J., Mentzer S.J., Strauss G. Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Thorac Surg 1992, 54:941-946.
10. Kim D.J., Yang W.I., Choi S.S., Kim K.D., Chung K.Y. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review. Chest 2005, 127:755-761.
11. Lucchi M., Ricciardi R., Melfi F., Duranti L., Basolo F., Palmiero G., Murri L., Mussi A. Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment. Eur J Cardiothorac Surg 2009, 35:812-816. [discussion 816].
12. Tsukaguchi M., Shimamura M., Ikeda K., Urai Y., Sasaki I., Deguchi K., Touge T., Takeuchi H., Kuriyama S. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy. J Neurol Sci 2005, 231:85-88.
13. Taguchi T., Suehiro T., Toru K., Ogami N., Takata H., Hashimoto K. Pleural dissemination of thymoma showing tumor regression after combined corticosteroid and tacrolimus therapy. Eur J Intern Med 2006, 17:575-577.
14. Bisagni G., Rossi G., Cavazza A., Sartori G., Gardini G., Boni C. Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma. J Thorac Oncol 2009, 4:773-775.
15. Yoh K., Nishiwaki Y., Ishii G., Goto K., Kubota K., Ohmatsu H., Niho S., Nagai K., Saijo N. Mutational status of EGFR and KIT in thymoma and thymic carcinoma. Lung Cancer 2008, 62:316-320.
16. Ohmi M., Ohuchi M. Recurrent thymoma in patients with myasthenia gravis. Ann Thorac Surg 1990, 50:243-247.
17. Margaritora S.C.A., Cusumano G., Meacci E., D'Angelillo R., Bonassi S., Carnassale G., Porziella V., Tessitore A., Vita M.L., Lauriola L., Evoli A., Granone P. Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg 2010, 89:245-252.
18. Deschamps C., Bernard A., Nichols F.C., Allen M.S., Miller D.L., Trastek V.F., Jenkins G.D., Pairolero P.C. Empyema and bronchopleural fistula after pneumonectomy: factors affecting incidence. Ann Thorac Surg 2001, 72:243-247. [discussion 248].
19. Deschamps C., Allen M.S., Miller D.L., Nichols F.C., Pairolero P.C. Management of postpneumonectomy empyema and bronchopleural fistula. Semin Thorac Cardiovasc Surg 2001, 13:13-19.
20. Endo M., Nakagawa K., Ohde Y., Okumura T., Kondo H., Igawa S., Nakamura Y., Tsuya A., Murakami H., Takahashi T., Yamamoto N., Ito I., Kameya T. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 2008, 61:350-355.
21. Liu R.S., Yeh S.H., Huang M.H., Wang L.S., Chu L.S., Chang C.P., Chu Y.K., Wu L.C. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Eur J Nucl Med 1995, 22:1402-1407.
22. Ito H., Shimada K., Isogami K., Kondo T., Kaneta T., Takahashi S., Fukuda H. Recurrent thymoma: radiological (CT and FDG-PET) and histological (WHO criteria) features. Radiat Med 2006, 24:292-296.
23. Kim J.B.L.S., Park S.I., Kim Y.H., Kim D.K. Risk factor analysis for postoperative acute respiratory distress syndrome and early mortality after pneumonectomy: the predictive value of preoperative lung perfusion distribution. J Thorac Cardiovasc Surg 2010, 140:26-31.
24. Jeon K., Yoon J.W., Suh G.Y., Kim J., Kim K., Yang M., Kim H., Kwon O.J., Shim Y.M. Risk factors for post-pneumonectomy acute lung injury/acute respiratory distress syndrome in primary lung cancer patients. Anaesth Intensive Care 2009, 37:14-19.
25. Sugarbaker D.J., Jaklitsch M.T., Bueno R., Richards W., Lukanich J., Mentzer S.J., Colson Y., Linden P., Chang M., Capalbo L., Oldread E., Neragi-Miandoab S., Swanson S.J., Zellos L.S. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004, 128:138-146.